1 / 28

Brain Tumors in Pediatrics

Brain Tumors in Pediatrics. Resident Education Lecture Series. Brain Tumors - Background. 20-30% of cancers in children 2500-3000 new diagnoses/year 2 nd most common neoplasm Most occur before age 10 years Male/Female = 1.3/1.0 60-70% 5 year survival.

lmeade
Télécharger la présentation

Brain Tumors in Pediatrics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Brain Tumors in Pediatrics Resident Education Lecture Series

  2. Brain Tumors - Background • 20-30% of cancers in children • 2500-3000 new diagnoses/year • 2nd most common neoplasm • Most occur before age 10 years • Male/Female = 1.3/1.0 • 60-70% 5 year survival

  3. Relative Incidence of Brain Tumors in Children Table 25-1. Approximate incidence of common CNS tumors in children. Pizzo & Poplack

  4. Location – Supra vs. Infra • Supratentorial 25-40% • Astrocytoma, low grade 8-20% • Astrocytoma, high grade 6-12% • Ependymoma 2-5% • Mixed glioma 1-5% • Ganglioglioma 1-5% • Oligodendroglioma 1-2% • PNET 1-2% • Choroid plexus tumor 1-2% • Meningioma 1-2% • Germ Cell Tumors 1-2% • Other 1-3%

  5. Location – Supra vs. Infra • Infratentorial 45-60% • Medulloblastoma (PNET) 20-25% • Astrocytoma, low grade 12-18% • Ependymoma 4-8% • Brain stem glioma, high grade 3-9% • Brain stem glioma, low grade 3-6% • Other 2-5%

  6. Brain Tumors - Signs/Symptoms • Increased intracranial pressure - symptoms • Headache (am) • Nausea/vomiting (am) • Double vision • Head tilt • Decreased alertness • Lethargy/irritability • Poor feeding, FTT • Endocrine dysfunction • Unexplained behavior changes - affect, motivation, energy level

  7. Brain Tumors – Signs/Symptoms • Increased ICP – Signs • Papilledema, optic atrophy • Loss of vision • OFC (head circumference) increased • Bulging fontanelles, spreading sutures • “Setting sun” sign (Parinaud syndrome) • Increased blood pressure, low pulse  herniation?

  8. Posterior Fossa primary Ataxia Tremors Dysarthria Stiff neck Papilledema Brainstem primary Extremity weakness Cranial nerve signs double vision facial weakness swallowing dysfunction Posterior Fossa & Brainstem Tumors - Clinical Features

  9. Hemispheric Tumors – Clinical Features • Hemiparesis • Hemianopsia • Aphasia • Seizures

  10. Treatment Tumor Type Surgery XRT Chemo Medulloblastoma +++ CrSp +++ Low grade astro +++ focal ---- cerebellar +++ ???? ---- optic glioma NO ???? ???? High grade astro/GBM +++ +++ ? Brain stem glioma (exophytic) focal ? Ependymoma +++ focal ---- Germ cell tumor ? bx +++ +++

  11. Treatment - Surgery • In general, needed for diagnosis - exceptions: GCT, BSG • Ideal is gross total resection Balance prognosis vs. morbidity • Debulking, shunts, reservoirs - for symptom/ICP reduction, therapy

  12. Treatment – Radiation Therapy • Potential for use in all brain tumors • exceptions: choroid plexus tumors • Neuro-axis prophylaxis (cranio-spinal rx) • if tumor disseminates via CSF • Concerns for long term effects • neuro-cognitive • hearing • secondary cancers • endocrine • skeletal growth

  13. Therapy - Chemotherapy • Adjunct therapy in most cases • particularly in GCT, medulloblastoma • Of interest in young children • (avoid or prolong XRT) • Blood brain barrier may be limiting • Newer studies suggest this may not be so • Local delivery via pumps/reservoir/IT

  14. Medulloblastoma/PNET Similar histology, different tumor names based on location. • Therapies vary • Medulloblastoma - posterior fossa • PNET - supratentorial • Pineoblastoma - pineal region • median age 5 years • M:F = 2:1 • propensity to disseminate • 1/3 with metastatic disease at diagnosis

  15. Medulloblastoma Prognostic Factors • Age - Younger tend to do worse • Extent of resection • Non-posterior fossa tumors • Non-localized disease • Standard risk 70-80% 5 yr survival High risk 50% what are risk groups?

  16. Medulloblastoma • CSF dissemination • check for leptomeningeal spread • brain/spine MRI, LP • Can spread to lung, liver, BM, bone, LN’s – rare • Difference between supratentorial PNET (sPNET), medulloblastoma, and pineoblostoma?

  17. Ependymoma • 10% of childhood brain tumors • Median age = 3-4 yrs • 2/3 of primary in posterior fossa • May have leptomeningeal spread - MRI of brain/spine, CSF • Prognostic factors: • Extent of resection!!! • Age: some reports of better survival if > 5-7 years at diagnosis • Histology

  18. Ependymoma - continued • Extent of resection most important • Near to gross total resection 50-75% • Less than NTR 0-30% • Radiation therapy helps survival • Reduces local recurrence • Chemotherapy has not shown efficacy • Recurrence is rarely fixable

  19. Brain Stem Gliomas • Diffuse intrinsic pontine gliomas • median survival = 6-9 months • death within 2 years > 90% • Radiation - transient clinical improvement • Low grade gliomas • tectal, exophytic, extra-medullary • highly enhancing on MRI • more indolent

  20. Low Grade Astrocytoma/Glioma • 30-35% of CNS tumors • 40-50% supratentorial, virtually anywhere • M:F = 2:1 • Association with NF-1 • more indolent course • GTR  >90% 5 year survival • RX • Radiation • Chemo if symptomatic, progressive, or recurrent

  21. Brain Tumors in < 3 year olds • 60-70% supratentorial • XRT has significant neuro-cognitive effects • Goal of therapies: • Delay XRT to at least 3 yrs old with chemotherapy  most relapse prior to XRT • Current study • Short course (16 wks) chemo • 2nd look surgery • Focal (conformal) XRT • Maintenance chemotherapy

  22. Complications From Tumor/Therapy • Neurological deficits • limb paresis • Rehab/PT/OT, support • swallowing/speech dysfunction • ENT, Speech therapy • Nutrition issues • neuro-cognitive deficits • School/education issues • Social interaction issues • endocrine dysfunction • end-organ damage • kidney, liver, hearing, neuropathy

  23. From ABP Certifying Exam Content Outline • Recognize the signs and symptoms of craniopharyngioma • Recognize the clinical manifestations of brain tumor • Recognize the physical characteristics of a headache due to increased intracranial pressure • Differentiate the clinical manifestations of spinal cord compression (eg, from a tumor) from those of other myelopathies, and evaluate appropriately

  24. Credits • Sachin Jogal MD

More Related